🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06818240
Recruiting Not applicable

Transcranial Direct Current Stimulation Enhances Dual-task Performance in Stroke

NCT06818240 · tracked via the Priya Life Science China tracker
Sponsor
The Hong Kong Polytechnic University
Phase
Not applicable
Started
2024-11-01
Last updated
2025-02-10

Condition(s) studied

Chronic Stroke

Investigational drug(s) / intervention(s)

Active transcranial direct current stimulationSham transcranial direct current stimulation

Active transcranial direct current stimulation: In the active tDCS session, real stimulation was delivered via a current stimulator (DC-STIMULATOR MC, NeuroConn, Germany) using saline-soaked 4×6 cm² electrodes. The anode was positioned over the left-DLPFC identified as F3 according to the 10-20 international EEG system, and the cathode over the right supraorbital ridge.

Sham transcranial direct current stimulation: In the Sham tDCS session, Sham stimulation was delivered via a current stimulator (DC-STIMULATOR MC, NeuroConn, Germany) using saline-soaked 4×6 cm² electrodes. The anode was positioned over the left-DLPFC identified as F3 according to the 10-20 international EEG system, and the cathode over the right supraorbital ridge.

Study summary

Stroke often impairs lower limb control, resulting in gait abnormalities and difficulties in dual-task performance, such as walking while engaging in cognitive activities. This study examines the effects of a single session of transcranial direct current stimulation (tDCS) targeting the left dorsolateral prefrontal cortex (DLPFC) on dual-task walking performance in individuals with chronic stroke. Using a cross-over design, participants will undergo two sessions (active or sham tDCS, 7 ± 2 days apart) of stimulation at 2 mA for 30 minutes. Walking performance will be measured using single and dual-task conditions combining motor (e.g., 20 m walk) and cognitive tasks (e.g., word association, random number recall). Primary outcomes include walking speed (m/s), stride length (m), and dual-task cost (DTC) for mobility and cognitive speed.

The study aims to evaluate tDCS as a potential tool to reduce DTC, improve dual-task performance, and improve daily function and quality of life in stroke survivors. Results may guide the development of tailored dual-task interventions in stroke rehabilitation.

Eligibility

Sex
ALL
Min age
50 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * age between 50 and 80 years * at least 6 months post-first-ever stroke with unilateral motor deficits * ability to walk independently for at least 10 m without the use of walking aids * a score of 24 or higher on the Mini-Mental State Examination (MMSE) Exclusion Criteria: * unstable medical conditions, such as heart failure, uncontrolled hypertension, or cancer * presence of other comorbidities that could interfere with gait * history of contraindications to tDCS, such as epilepsy or metal implants * history of head injury, head surgery, or lower limb orthopedic issues

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Hong Kong Polytechnic University Hong Kong China Recruiting

More The Hong Kong Polytechnic University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06818240 on ClinicalTrials.gov ↗ ← All trials in China